Niu Y - Search Results

1

Olsalazine Sodium Increases Renal Urate Excretion by Modulating Urate Transporters in Hyperuricemic Animals.

Niu Y, Yang P, Li H, Li Q, Lin H, Gao L, Li L. Niu Y, et al. Biol Pharm Bull. 2020 Nov 1;43(11):1653-1659. doi: 10.1248/bpb.b20-00362. Epub 2020 Aug 28. Biol Pharm Bull. 2020. PMID: 32863294 Free article.

2

In vivo insulin-mimetic activity of [N,N'-1,3-propyl-bis(salicyladimine)]oxovanadium(IV).

Xie M, Xu G, Li L, Liu W, Niu Y, Yan S. Xie M, et al. Among authors: niu y. Eur J Med Chem. 2007 Jun;42(6):817-22. doi: 10.1016/j.ejmech.2006.12.021. Epub 2007 Jan 12. Eur J Med Chem. 2007. PMID: 17343957

3

Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.

Niu Y, Liu W, Tian C, Xie M, Gao L, Chen Z, Chen X, Li L. Niu Y, et al. Eur J Pharmacol. 2007 Oct 31;572(2-3):213-9. doi: 10.1016/j.ejphar.2007.05.071. Epub 2007 Jun 19. Eur J Pharmacol. 2007. PMID: 17651728

4

The antilipolytic action of bis(alpha-furancarboxylato)oxovanadium(IV) in adipocytes.

Gao L, Niu Y, Liu W, Xie M, Liu X, Chen Z, Li L. Gao L, et al. Among authors: niu y. Clin Chim Acta. 2008 Feb;388(1-2):89-94. doi: 10.1016/j.cca.2007.10.014. Epub 2007 Oct 18. Clin Chim Acta. 2008. PMID: 17991430

5

[Insulino-mimetic effects of bis (alpha-furancarboxylato) oxovanadium (IV) in vitro].

Li YR, Gao LH, Ma YL, Niu YF, Liu WP, Li L. Li YR, et al. Yao Xue Xue Bao. 2008 Mar;43(3):318-22. Yao Xue Xue Bao. 2008. PMID: 18630272 Chinese.

6

Bis(alpha-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.

Zuo YQ, Liu WP, Niu YF, Tian CF, Xie MJ, Chen XZ, Li L. Zuo YQ, et al. J Pharm Pharmacol. 2008 Oct;60(10):1335-40. doi: 10.1211/jpp/60.10.0009. J Pharm Pharmacol. 2008. PMID: 18812026

7

A new insulin-enhancing agent: [N,N'-bis(4-hydroxysalicylidene)-o-phenylene-diamine]oxovanadium(IV) and its permeability and cytotoxicity.

Xie MJ, Li L, Yang XD, Liu WP, Yan SP, Niu YF, Meng ZH. Xie MJ, et al. Eur J Med Chem. 2010 Jun;45(6):2327-35. doi: 10.1016/j.ejmech.2010.02.010. Epub 2010 Feb 10. Eur J Med Chem. 2010. PMID: 20207051

8

Effect of the chloro-substitution on lowering diabetic hyperglycemia of vanadium complexes with their permeability and cytotoxicity.

Xie MJ, Niu YF, Yang XD, Liu WP, Li L, Gao LH, Yan SP, Meng ZH. Xie MJ, et al. Eur J Med Chem. 2010 Dec;45(12):6077-84. doi: 10.1016/j.ejmech.2010.10.013. Epub 2010 Oct 16. Eur J Med Chem. 2010. PMID: 21036421

9

3,5,2',4'-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitor.

Niu Y, Zhu H, Liu J, Fan H, Sun L, Lu W, Liu X, Li L. Niu Y, et al. Chem Biol Interact. 2011 Feb 1;189(3):161-6. doi: 10.1016/j.cbi.2010.12.004. Epub 2010 Dec 15. Chem Biol Interact. 2011. PMID: 21167141

10

Reducing effect of mangiferin on serum uric acid levels in mice.

Niu Y, Lu W, Gao L, Lin H, Liu X, Li L. Niu Y, et al. Pharm Biol. 2012 Sep;50(9):1177-82. doi: 10.3109/13880209.2012.663763. Pharm Biol. 2012. PMID: 22881143 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,474 results

Search Page

Filters